Study of Vitamin D in Untreated Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kimmie Ng, MD, MPH
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mountain States Tumor Institute at St. Luke'S Regional Medical Center
Boise, Idaho, United States
- Mountain States Tumor Institute- Fruitland
Fruitland, Idaho, United States
- Mountain States Tumor Institute - Meridian
Meridian, Idaho, United States
- Mountain States Tumor Institute- Nampa
Nampa, Idaho, United States
- Mountain States Tumor Institute- Twin Falls
Twin Falls, Idaho, United States
- the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, Illinois, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Lowell General Hospital
Lowell, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, United States
- Newton-Wellesley Hospital
Newton, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center in Clinical Affiliation With South Shore Hospital
South Weymouth, Massachusetts, United States
- New Hampshire Oncology Hematology-P.A.
Concord, New Hampshire, United States
- New Hampshire Oncology Hematology-P.A.
Hooksett, New Hampshire, United States
- New Hampshire Oncology Hematology-P.A.
Laconia, New Hampshire, United States
- Dana-Farber/new Hampshire Oncology-Hematology
Londonderry, New Hampshire, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Apr 2012
- Primary completion
- 9 Nov 2019
- Completion
- 9 Nov 2019
- Last update posted
- 26 Apr 2022
- Registered enrollment
- 139
- Registry id
- NCT01516216
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.